We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Agronomics Limited | LSE:ANIC | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 5.00% | 8.40 | 8.10 | 8.40 | 8.25 | 8.00 | 8.00 | 1,211,081 | 16:35:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 30.88M | 22.37M | 0.0222 | 3.72 | 83.28M |
TIDMANIC
RNS Number : 4172R
Agronomics Limited
05 November 2021
5th November 2021
Agronomics Limited
("Agronomics" or the "Company")
Net Asset Value calculation to 30 September 2021
Agronomics Limited (AIM:ANIC), the leading listed company focused on the field of cellular agriculture , announces that the unaudited Net Asset Valuation ("NAV") calculation as at closing on 30 September 2021 was 12.99 pence per share, including un-invested cash of GBP55.1 million. Net Assets stand at GBP103.9 million, including investments of GBP50.5 million. This quarter's NAV per share represents an increase of 10.93% from the previous quarter's NAV of 11.71 pence per share.
The share price of 27.5 pence at the 30 September 2021 close represents a premium of 111.7% to the NAV per share. Under IFRS, the Company's unquoted investments are carried at cost or the most recent priced funding round.
Richard Reed, Chairman of Agronomics, commented: -
"Our assets have continued to perform well and the broader developments across our holdings in the period have further strengthened our position as the largest listed company focused on the field of cellular agriculture. Large and well-known institutional investors have begun investing in our portfolio companies, with this being a positive for both the Company and the wider industry as a whole.
We continue to believe that there is significant intrinsic value not yet reflected in our financial accounts which will be recognised as our portfolio companies complete further priced funding rounds."
During July 2021, BlueNalu, Inc, a leading innovative food company producing a variety of seafood products directly from fish cells, and CellX Limited, a China-based cellular agriculture company, reached the Semi-Finals of XPRIZE's 'Feed the Next Billion' competition, with the US $15 million competition being aimed at reinventing how humanity will feed future generations by incentivising the production of structured chicken breast or fish fillet alternatives that replicate or outperform conventional chicken and fish in access, environmental sustainability, animal welfare, nutrition and health, as well as taste and texture.
On 16 July 2021, warrants issued by the Company as part of the May 2021 fundraise commenced trading on the JP Jenkins trade desk.
On 21 July 2021, Shiok Meats Pte. Ltd. ("Shiok Meats"), the leading cell-based crustacean meat company, completed a bridge funding round from South Korean strategic investors Woowa Brothers Asia Holdings and CJ CheilJedang Corporation, as well as Vietnamese seafood exporter Vinh Hoan Corporation. No material adjustments were made to the carrying value of the Shiok Meats investment.
On 13 September 2021, Formo Bio GmbH (previously named LegenDairy), Europe's first cellular agriculture company developing cultivated dairy products, completed a US $50 million Series A funding round, with Agronomics acquiring 1,191 Series A Preferred Shares for a EUR3.15 million investment. Agronomics now holds a total of 4,030 shares in Formo, representing an equity ownership of 5.94% on a fully diluted basis. Completion of the Series A funding round resulted in a 7.5x uplift on the original investment, an IRR of 225%, and an unrealised gain of GBP5.6 million.
On 20 September 2021, Agronomics announced that it led the Series A funding round of VitroLabs Inc ("VitroLabs"), a biotechnology company focused on producing leather via its innovative and unique cell culture process, with a US $7 million investment. The existing SAFE and CLN investments, which totaled US $3.5 million, converted into Series A shares on completion. The uplift resulted in an unrealised gain of US $2.25 million and an IRR of 40%.
On 22 September 2021, Mosa Meat B.V. ("Mosa Meat"), a global food technology company pioneering a cleaner, kinder way of making real beef, announced that it secured funding from Leonardo DiCaprio, who will now act as an advisor to Mosa Meat.
On 28 September 2021, Simply Foods, Inc., trading as New Age Meats, a cultivated and plant-based meat startup in Berkeley, CA with an initial focus on pork, closed a US $25 million Series A funding round led by Hanwha Solutions Corporation, a South Korean conglomerate. The Series A financing represents a 5.14x uplift on the original cash investment by Agronomics, with an IRR of 119%, including an unrealised gain on cost of US $2.90 million.
On 29 September 2021, Agronomics disposed of its total holding of 40,000 shares in Oritain Global Limited for NZ $1.36 million (approximately GBP0.7 million), representing an IRR of 74%.
Unaudited to 30 September 2021 GBP Fixed Assets Investments 50,476,414 Current Assets Uninvested Cash 55,062,325 Sundry Debtors 53,068 Current Liabilities Trade and Other Creditors (103,039) Future investment commitment (1,592,178) ------------------------------ Net Assets 103,896,590 Capital and Reserves Share Capital 799 Share Premium 91,458,482 Retained Earnings 12,437,309 ------------------------------ Net assets 103,896,590 Shares in Issue 799,606,383 Net Asset Value per 12.99 pence share
The quoted investments within the portfolio are valued under IFRS at bid price.
Portfolio Details
Investments as at 30 September Value (GBP) % of Total Portfolio 2021 Quoted holdings 656,206 1.30% Unquoted holdings 48,228,030 95.55% Committed future investment 1,592,178 3.15% Total 50,476,414 100%
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
For further information please contact:
Agronomics Beaumont Cenkos Peterhouse TB Cardew Limited Cornish Limited Securities Capital Plc Limited The Company Nomad Joint Broker Joint Broker Public Relations ------------------ ------------------ --------------------- ------------------------ Richard Reed Roland Cornish Giles Balleny Lucy Williams Ed Orlebar Denham Eke James Biddle Michael Johnson Charles Goodfellow Joe McGregor ------------------ ------------------ --------------------- ------------------------ +44 (0) 20 7930 0777 +44 (0) 1624 +44 (0) 7738 724 639396 +44 (0) 207 +44 (0) 207 +44 (0) 207 630 info@agronomics.im 628 3396 397 8900 469 0936 agronomics@tbcardew.com ------------------ ------------------ --------------------- ------------------------
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NAVBLBDBUSGDGBS
(END) Dow Jones Newswires
November 05, 2021 03:00 ET (07:00 GMT)
1 Year Agronomics Chart |
1 Month Agronomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions